Fundraising

What Pre-Seed Valuation Numbers Look Like Right Now

Benchmarks, traps, and the mechanics investors use but rarely explain

May 26, 2026 - 10 min read

The Number That Matters Most Is Not What You Think

I see it constantly - founders walking into a pre-seed raise with a valuation already in mind. They picked it from a blog post, a friend's round, or a gut feeling about what sounds credible. The number is usually wrong - chosen without understanding how investors arrive at valuations.

The mechanic founders miss: at pre-seed, investors do not model your business and work forward to a fair value. They anchor to a target ownership percentage - typically 15 to 20 percent per round - and reverse-engineer the valuation from whatever you are raising. Raise $450K and they want 15 percent? Your valuation is $3M. Raise $900K at the same ownership target? Your valuation doubles to $6M. Same dilution. Double the valuation. The variable that moved was your check size, not your company.

Once you understand that mechanic, the benchmark data starts to make a lot more sense.

The Hard Numbers on Pre-Seed Valuation Right Now

Carta tracks tens of thousands of convertible instruments on its platform and publishes quarterly pre-seed data. That data is the most reliable baseline available for US founders.

For post-money SAFEs, the median valuation caps break down like this:

Rounds under $250K: median val cap of $7.5M
Rounds between $250K and $1M: median val cap of $10M
Rounds between $1M and $2.5M: median val cap of $15M

The PitchBook-NVCA Venture Monitor puts the median pre-seed pre-money valuation at $7.7M as of Q3, down slightly from $8.0M in Q2. That number covers all round sizes and geographies, which is why it skews lower than the Carta SAFE-specific caps.

Both numbers are the middle of the distribution. Where you land depends on who you are, what you are building, and where you are building it.

Valuation Caps Are Rising While Check Sizes Fall

Valuation caps are going up while check sizes are going down.

From Carta Q1 data, there were 3,400 rounds under $1M versus only 1,700 above $1M. A year prior, it was 3,800 under versus 2,900 over. Smaller rounds now dominate. Yet caps on those small rounds have risen - the median cap for a sub-$250K round jumped from $6.5M to $7.5M in a single quarter.

The paradox extends further. The median pre-seed raise has been trending down toward $700K while valuation caps have climbed to a median of around $17M. Compression. Investors are writing smaller checks at higher valuations because AI-driven productivity gains are changing how much capital a founder needs to prove a concept.

Carta put it plainly: rising val caps for small rounds suggest investors now see higher upside for very early-stage startups, likely influenced by AI productivity gains.

Dilution Is Where the Math Hides

A high valuation cap feels like a win. It usually is not the whole story.

For rounds raising $1M to $1.9M, the median expected dilution is 15.6 percent. For rounds in the $5M to $5.9M range, median dilution climbs to 23.7 percent. The largest SAFE rounds can produce more dilution than a clean priced seed round of similar size.

This matters because of how the math compounds. If you give away 20 percent at pre-seed, then 20 percent at seed, then 20 percent at Series A, you own 51 percent of your company before a single growth check arrives. Founders who optimize for headline valuation without tracking dilution often hit their Series A with founders under 40 percent - a red flag for later-stage investors.

The standard SAFE structure right now is post-money with a valuation cap but no discount. When a discount does appear, it is almost always 20 percent - that is the case in 63 percent of SAFEs that include a discount at all.

The 5M Ceiling Rule

One of the most cited data points among active pre-seed investors comes from VC analysis of upround outcomes. Of companies that raised at a valuation cap below $15M, nine out of fourteen went on to raise an upround at roughly a 3x multiple. Of companies that raised above a $15M cap, zero out of seven raised an upround.

The sample is small. But as a directional signal, it is striking. Founders who push for a high pre-seed valuation to feel better about the round are often setting a ceiling that kills their Series A story. If you raise at $20M and your seed investor expects a $60M valuation, you need to triple before your seed round closes. I have watched company after company fail to do that in 18 months.

The valuation that gives you a reasonable path to an upround is the one worth fighting for.

What SAFEs Look Like in Practice

SAFEs now dominate pre-seed financing to a degree that was not true even a few years ago. SAFEs accounted for 92 percent of all pre-priced pre-seed rounds in Q3, climbing to 93 percent by Q4. Convertible notes are down to just 7 percent of pre-priced deals.

Post-money SAFEs are effectively the only game in town. The post-money structure went from just over 60 percent to nearly 90 percent of all SAFEs over a four-year span. If you are using a pre-money SAFE, you are using legacy paperwork that makes founders and investors both nervous.

The point at which companies move to priced equity has shifted from around $3M to $4M in total raised. Founders are staying on SAFEs longer, and the market has accepted it.

AI Startups Are Playing a Different Game

AI software companies command median valuations around $19M at the seed stage versus a broader market median of $15M. That is a 27 percent premium for the same round structure.

Pre-seed rounds for SaaS companies typically land in the $5M to $10M cap range with $500K to $1M raises and 10 to 15 percent dilution. What is being called mega-pre-seed for AI companies often runs $25M to $50M valuation caps on $2M to $5M raises - with lower dilution percentage-wise because the caps are so high relative to the raise amount.

AI is capturing 41.7 percent of all seed capital right now according to Carta data compiled by FutureSight. That concentration is distorting benchmarks. If you are building a non-AI company and comparing yourself to AI pre-seed deals, you are benchmarking against a completely different investor pool with completely different return expectations.

The broader headline: early-stage valuations are on a strong run. The median seed post-money valuation hit $24M in a recent quarter - up from $18M a year prior. The Series A median hit $78.7M in the same period, up 37 percent year-over-year. Pre-seed is being pulled upward by this tide, but not uniformly.

Geography Still Matters More Than Founders Admit

The top five US metros for pre-seed cash raised are the Bay Area, New York, Boston, Los Angeles, and Washington DC. The Western census region alone takes in half of all pre-seed fundraising in the US.

For top-decile seed valuations, 66 percent go to Bay Area (44 percent) or New York (22 percent) startups. Bay Area pre-seed caps are 30 to 50 percent higher than the national median.

You can raise from Denver or Austin. You are not competing on the same valuation curve. Nashville recently broke into the top 20 US metros for pre-seed fundraising after pulling in $32M over twelve months - so the geography map is expanding, slowly.

How Accelerators Price the Round for You

Accelerators set effective valuations whether founders realize it or not. The terms on major programs:

Y Combinator: $500K for 7 percent plus an MFN SAFE
Sequoia Arc: approximately $1M for 10 percent
a16z Speedrun: $500K for 10 percent plus $500K follow-on option
HF0 Residency: $1M for approximately 5 percent

YC's $500K at 7 percent implies a post-money valuation of about $7.1M. That is below the median cap for a $250K to $1M round - which means YC takes a slight discount in exchange for the brand, network, and demo day access. Some founders accept that trade. Others do not.

If you get into a top accelerator, take the deal. The network pays off faster than the dilution costs you. Do not confuse the accelerator's standard terms with what you can command outside the program.

The Sector Split That Changes Your Benchmarks

Industry matters as much as stage when setting valuation expectations.

Crypto and Web3 startups continue to command the highest median valuation caps in SAFE rounds, even though they make up a small slice of total pre-seed deal count. Biotech and pharma carry the fourth-largest share of pre-seed capital and also rank among the highest median caps - but they more often use convertible notes instead of SAFEs. Energy, biotech, and medical devices are the industries with the highest remaining representation of convertible notes.

SaaS remains the largest category by deal count. Healthtech raised $319M in pre-seed capital through Q3 alone - the third largest industry by total dollars and second by number of rounds. Healthtech deals above $2.5M carry a median val cap of $35M.

The Concentration Problem I Watch Founders Ignore Every Week

Pre-seed capital is not evenly distributed. In a recent quarter, 11,672 SAFEs and convertible notes were issued - representing $2.62 billion total. Fewer rounds, more money per round. The bottom 50 percent of startups on Carta that closed a round combined to bring in just 14 percent of all cash raised.

This is the concentration dynamic that changes how you should think about raising. The median tells you what the average deal looks like. But if you are not in the top half of companies by quality signals - team background, market size, early traction - you are not competing for the median deal.

The question is not what is the median pre-seed valuation. The question is what valuation can a company with my specific profile command. Those are different questions with different answers.

What Founders Are Doing With This Data

Active operators and early-stage investors are doing a few things consistently.

First: raise what you need for 18 to 20 months of runway, not the maximum the market will give you. The paradox of high-valuation pre-seed rounds is that they raise expectations without proportionally increasing the probability that you meet them.

Second: the modern pre-seed is often two rounds disguised as one. Founders raising $800K frequently do it in two tranches - $200K to $300K from a handful of operators to prove one specific thing, then a larger $500K to $600K wave once there is signal. You get a valuation anchor for the second tranche instead of negotiating blind.

Third: do not benchmark your valuation against AI outliers unless you are building AI. The 41.7 percent of seed capital going to AI has distorted public perception of what a normal pre-seed looks like. The median non-AI pre-seed is a $1M raise on a $10M cap with 10 to 15 percent dilution. That is the normal you are competing in.

Fourth: know the $15M ceiling principle. Companies that raise at caps above $15M have no track record of raising uprounds in the data sets that have been published. That does not mean a higher cap is always wrong - AI companies with genuine traction may justify it - but it means you need a specific reason to go above that number, not just confidence that your company is exceptional.

If you are doing outbound to investors and want to build a targeted list before your raise, Try ScraperCity free - it lets you search millions of contacts by title, industry, and company size so you can find pre-seed investors and angels before your round opens.

The Round Size Shift You Need to Know

Rounds under $250K now make up 45 percent of all pre-seed rounds - up from 39 percent just one quarter earlier. Rounds between $500K and $1M remain the most common band at 45 percent of deals. Rounds above $2M outside of AI are rare, under 5 percent of deals.

This matters for how you structure your ask. Walking into a pre-seed raise looking for $3M when the market is consolidating around sub-$1M raises means you are competing in a thin market. You need a compelling reason - typically AI traction, a prior exit, or existing enterprise commitments - to justify the top decile.

The cap table math from these round sizes: a $700K raise on a $10M cap gives you 7 percent dilution. A $700K raise on a $7M cap gives you 10 percent. The difference is meaningful over time as dilution compounds through later rounds. Pick the cap based on what gives you a clear 3x path by your next raise - not based on what sounds impressive in a pitch.

One More Thing on Valuation and Ownership

There is a lesson that gets learned the hard way in the startup ecosystem. Building something valuable and exiting with significant ownership are both required. You can run a company that generates over a million dollars a year and still leave the table with nothing if you gave away too much equity too early at too high a valuation that boxed you into bad subsequent terms.

Ownership either compounds in your favor or against you, and it starts at the pre-seed round. The founders who protect themselves at pre-seed are the ones who understand that valuation is a constraint as much as it is a reward.

A $20M pre-seed cap feels good. A $20M pre-seed cap that forces you to raise your seed at $60M to avoid a down round - with $800K ARR - is a trap. Set the valuation that gives you the best chance of raising the next round.

Frequently Asked Questions

What is a normal pre-seed valuation right now?

For post-money SAFEs, Carta data shows median caps of $7.5M for rounds under $250K, $10M for rounds between $250K and $1M, and $15M for rounds between $1M and $2.5M. The PitchBook-NVCA median pre-money figure sits at $7.7M across all round types. Geography and sector move these numbers significantly - Bay Area caps run 30 to 50 percent above the national median, and AI companies command a substantial premium.

Should I use a SAFE or a convertible note for my pre-seed?

SAFEs dominate pre-seed financing, accounting for 92 to 93 percent of pre-priced rounds in the most recent Carta data. The post-money SAFE with a valuation cap and no discount is the current standard. Convertible notes are now mostly used in biotech, energy, and medical devices. Unless your investors specifically request a note, a post-money SAFE is the expected instrument.

How much equity should I give up at pre-seed?

Median expected dilution for $1M to $1.9M SAFE rounds is 15.6 percent. For rounds under $250K, median dilution is around 5 to 6 percent. Investors typically anchor to a 15 to 20 percent ownership target per round, which means the valuation is largely reverse-engineered from the raise amount. Target keeping total pre-seed dilution under 15 percent if possible to protect your cap table for seed and Series A.

Does it matter if I am raising outside the Bay Area?

Yes. 66 percent of top-decile seed valuations go to Bay Area or New York startups. The Western census region captures half of all pre-seed fundraising in the US. That does not mean you cannot raise elsewhere - Nashville recently broke into the top 20 US metros for pre-seed capital - but you should expect median caps 20 to 30 percent lower outside major tech hubs and adjust your investor targeting accordingly.

What is the difference between a pre-seed and seed round?

Pre-seed typically uses SAFEs or convertible notes for raises under $4M, with founders at concept or early prototype stage. Seed rounds are increasingly priced equity rounds with median post-money valuations around $20M to $24M, and they now generally require meaningful traction - $50K to $200K ARR, strong retention data, or enterprise pilots. The gap between the two stages has widened as seed round sizes have grown.

Why does raising a higher valuation at pre-seed sometimes hurt you?

The upround data is stark: companies that raised at caps above $15M have shown zero upround success in tracked cohorts, while those below $15M went on to raise uprounds at roughly 3x in 9 out of 14 cases. A high pre-seed cap sets a floor for your seed valuation. If you raised at $20M, your seed investors expect $60M or more, which requires significant growth in a short window. Most companies cannot hit that bar, leading to flat rounds, down rounds, or difficulty raising at all.

How are AI startups changing pre-seed valuation norms?

AI startups are creating a two-tier market. Standard pre-seed deals land at $5M to $10M caps on $500K to $1M raises. AI-focused mega-pre-seeds are running $25M to $50M caps on $2M to $5M raises. AI is capturing 41.7 percent of all seed capital, which distorts the public perception of what a normal pre-seed looks like. Non-AI founders should benchmark against the non-AI distribution, not the AI outlier deals.